CONDENSED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
Operating expenses
Research and development	$ 42,651	$ 36,757
General and administrative	11,464	9,202
Total operating expenses	54,115	45,959
Loss from operations	(54,115)	(45,959)
Other income
Interest income	5,102	5,161
Total other income	5,102	5,161
Net loss	(49,013)	(40,798)
Other comprehensive income (loss):
Unrealized loss on available-for-sale securities, net	(929)	(19)
Total comprehensive loss	$ (49,942)	$ (40,817)
Net loss per share, basic (in dollars per share)	$ (0.46)	$ (0.43)
Net loss per share, diluted (in dollars per share)	$ (0.46)	$ (0.43)
Weighted-average shares outstanding, basic (in shares)	107,116,709	95,130,053
Weighted-average shares outstanding, diluted (in shares)	107,116,709	95,130,053